Founded on long-term technical innovation starting in 2010, Raycision Medical pioneered image-guided cancer radiotherapy. It developed advanced 3D optical molecular and CT multimodal imaging technologies, and upgraded precision radiotherapy systems in 2017. After its establishment, the company launched cutting-edge biomedical imaging and radiotherapy products, expanding domestic R&D layouts and empowering global scientific and clinical research with original core technologies.
Small animal models are widely used to investigate disease progression, biological mechanisms, treatment response, and drug distribution before clinical studies begin. To obtain meaningful data withou...
In preclinical radiation studies, a source that can deliver a selected dose is only the starting point. Researchers also need controlled dose rates, reproducible animal positioning, localized beam del...
In the rapidly evolving field of biomedical research, having cutting-edge tools is paramount. Among the many players in the industry, Raycision has carved out a niche as a leader in Imaging and Radiat...
